Literature DB >> 23944317

Sofosbuvir for previously untreated chronic hepatitis C infection.

Ching-Sheng Hsu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23944317     DOI： 10.1056/NEJMc1307641

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease.

Authors:  Ye Yu; Jing-feng Jing; Xian-kun Tong; Pei-lan He; Yuan-chao Li; You-hong Hu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2014-07-21       Impact factor: 6.150

2.  Treatment of Chronic Hepatitis C Infection with Sofosbuvir-Based Regimens in a Commercially Insured Patient Population.

Authors:  John Barron; Yiqiong Xie; Sze-Jung Wu; Jeff White; Joseph Singer; Bernard Tulsi; Alan Rosenberg
Journal:  Am Health Drug Benefits       Date:  2016-09

Review 3.  Impact of new treatment options for hepatitis C virus infection in liver transplantation.

Authors:  Elda Righi; Angela Londero; Alessia Carnelutti; Umberto Baccarani; Matteo Bassetti
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 4.  Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma.

Authors:  Ching-Sheng Hsu; You-Chen Chao; Hans Hsienhong Lin; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

5.  Hepatitis C virus genotypes and subtypes circulating in Mainland China.

Authors:  Ying Chen; Changshun Yu; Xueru Yin; Xiaolei Guo; Shangwei Wu; Jinlin Hou
Journal:  Emerg Microbes Infect       Date:  2017-11-01       Impact factor: 7.163

Review 6.  The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.

Authors:  Jiliang Shen; Chiung-Kuei Huang; Hong Yu; Bo Shen; Yaping Zhang; Yuelong Liang; Zheyong Li; Xu Feng; Jie Zhao; Lian Duan; Xiujun Cai
Journal:  J Cell Mol Med       Date:  2017-02-22       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.